Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New NHS program aims to tackle the emotional toll of type 1 diabetes

NCT ID NCT07193446

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new NHS pathway to help adults with type 1 diabetes manage diabetes distress—the worry, frustration, and burnout that often comes with the condition. The pathway trains healthcare teams to recognize and discuss distress during routine visits, and offers an online group program for those who need extra support. The study will enroll 110 adults with type 1 diabetes, along with their healthcare professionals and family members, to see if the approach is feasible and acceptable in the UK NHS.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Usual Care and REDUCE programme (behavioural interventions)
What this could lead to
If successful, this could lead to a practical NHS pathway to help adults with type 1 diabetes manage the emotional burden of their condition, improving quality of life.
What could go wrong
This is a small feasibility study, not a large trial. It tests whether the approach works in practice, not whether it improves health outcomes. The interventions may not be effective for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults with type 1 diabetes * People aged 18 years old and older * With a T1DM diagnosis of more than one year * Who used a Continuous Glucose Monitoring device 3 months prior to trial entry Health care professionals * Members of the multidisciplinary diabetes team * Who would like and be able to undertake training in Enhanced Usual Care (EUC) Family or friend * People aged 18 years or older * Is involved with the care of the participant * The participant has consented to the family member or friend to be involved in the study REDUCE Facilitators • Eligibility as per the role specification in Section 6.2.2 of study Protocol Exclusion Criteria: Adults with type 1 diabetes * Exclusion criteria will include those adults diagnosed less than one year ago. This is because the first 12 months following a diagnosis of T1DM is a period of unique stress due to the diagnosis, the acute onset, and requirement to learn complex new skills. Additionally, due to the honeymoon period, which can typically last up to a year, there is variety in the physiological trajectory which might have an impact that would be difficult to measure and account for in this study(Sokołowska, Chobot et al. 2016). * Women who are pregnant. This is because the additional burdens and anxieties this population is confronted with may risk confounding the trial findings * Exclusion of adults with current mental health diagnoses with current symptoms (e.g. psychosis or substance abuse or severe depression), will be evaluated and determined on a case-by-case basis by clinical care teams. Health care professionals • People who are unwilling or unable to take on additional workload associated with D-stress e-learning and delivery of Enhanced Usual Care. Family or friend • Participant with type 1 diabetes has not given consent for a family member or friend to participate in the study REDUCE Facilitators * • Professional accreditation with one of the following professional bodies: Nursing \& Midwifery Council, Health \& Care Professionals Council, British Association for Counselling \& Psychotherapy, and UK Council for Psychotherapy. * Professional or personal understanding of Type 1 diabetes * Professional or personal understanding of NHS diabetes care and guidelines * Professional or personal understanding of diabetes distress * Professional understanding of mental and emotional health * Professional experience of in-person and/or online group facilitation especially in managing diverse needs within a group and the expression of strong emotions * Willingness to be a research participant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes type 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Guy's and St Thomas' Hospitals NHS Trust

    RECRUITING

    London, United Kingdom

  • Royal United Hospitals Bath

    RECRUITING

    Bath, United Kingdom

  • University Hospitals Leicester NHS Trust

    RECRUITING

    Leicester, LE1 7RH,, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.